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OBJECTIVE: To describe the clinical, surgical, biochemical, radiological and electrophysiological fea-
tures of 43 Saudi children with persistent hyperinsulinaemic hypoglycaemia of infancy (PHHI) who have
been followed since 1983.
METHODS: Data from 43 patients were retrospectively analysed. PHHI was diagnosed on the basis of high
intravenous glucose requirement, high insulin to glucose ratio, negative urinary ketones and normal tandem
mass spectrometry. The patients were assessed radiologically by brain magnetic resonance imaging and/or
computed tomography and electrophysiologically by brain stem auditory evoked potential, visual evoked
response and electroencephalogram. Patients who failed medical therapy received near total pancreatectomy. 
RESULTS: The patients were severely hypoglycaemic and intolerant to fast. Hypoglycaemic convulsion
was the most commonly presenting complaint. Eighteen patients were developmentally delayed and 14
of them had brain atrophy. All patients, except nine, did not respond to medical treatment and under-
went surgery. Four pancreatectomized patients developed diabetes and two had malabsorption. One baby
had 180 cm resection of gangrenous bowel most likely secondary to octreotide. No common bile duct
injury was encountered. One patient was treated medically during childhood and developed diabetes and
gained weight during adolescence. 
CONCLUSION: PHHI is a relatively common and serious disease among Saudi children. Early interven-
tion is necessary to avoid neurological damage in patients who are severely hypoglycaemic and unrespon-
sive to medical therapy. Surgically and probably medically treated patients are at a high risk of developing
diabetes, which could be the natural outcome of this disease. Care and spending time during surgery to
visualize the common bile duct help in avoiding its injury. [Asian J Surg 2006;29(3):207–11]
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Introduction
Persistent hyperinsulinaemic hypoglycaemia of infancy
(PHHI), formally known as nesidioblastosis, is a glucose
metabolic disorder characterized by profound hypogly-
caemia and inappropriate secretion of insulin.1 The disease
includes focal and diffuse forms, both have a similar clin-
ical presentation but different molecular mechanism. Its
incidence in the general population is 1/50,000 live births,2
but in areas with high inbreeding such as the Kingdom of
Saudi Arabia, the incidence may be as high as 1/2,500,
where most of the cases are familial.3 This familial form
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may be caused by recessive or dominant defects in the sul-
fonylurea receptor (SUR1) gene,4 potassium inward recti-
fying receptor (Kir6.2) gene,5 glutamate dehydrogenase
gene6 or the glucokinase gene.7
Babies with PHHI run a high risk of severe neurologi-
cal damage secondary to severe hypoglycaemia unless
immediate and adequate steps are taken.8 These steps
should include high glucose infusion and medical treat-
ment with diazoxide and octreotide (somatostatin ana-
logue). The diffuse form is usually sensitive to medical
treatment. Elective surgery (near or subtotal pancreatec-
tomy) or resection of the focal lesion has to be performed
as soon as possible, particularly in cases where medical
treatment is not successful.9
Patients and methods
We retrospectively analysed the records of 43 children (26
girls and 17 boys) (King Faisal Specialist Hospital &
Research Centre in Riyadh, Saudi Arabia) who were diag-
nosed with PHHI between 1983 and 2004. The disease was
diagnosed on the basis of high intravenous glucose infu-
sion ≥ 12 mg/kg/minute, insulin to glucose ratio ≥ 0.3, 30
minute-glucose increment ≥ 30 mg/dL (1.67 mmol/L) in
response to 0.5 mg intramuscular glucagon, negative
urine ketones and normal blood spot acylcarnitine pro-
file determined by tandem mass spectrometry (MS). All
patients had assessment of growth hormone, adenocorti-
cotropic hormone (ACTH), insulin and cortisol levels.
Patients were also assessed radiologically by brain mag-
netic resonance imaging (MRI), computed tomography
(CT) or both. Patients were evaluated electrophysiologi-
cally by electroencephalogram, brain stem auditory
evoked potential and visual evoked response. Echocardio-
gram was performed in patients who were suspected to
have cardiac disease. Our management policy was to
maintain blood sugar level at ≥ 70 mg/dL (3.88 mmol/L).
Medical therapy included diazoxide (maximum dose,
25 mg/kg/day) and octreotide (maximum dose, 40 mg/
kg/day) as well as intravenous glucose infusion. If med-
ical therapy as initial management failed (lack of response
or development of side effects), the patient was subjected
to near total pancreatectomy (85–95%). The surgical tech-
nique was usually done by an upper abdominal incision
and through the cologastric omentum. The pancreas was
usually exposed from the tail to the head; the pancreatic
dissection usually began from the tail. The splenic vessels
were usually dissected off the pancreas using a bipolar
diathermy. The large vessels that cross into the pancreas
were ligated and tied by 3/0 silk. At the uncinate process,
dissection was carried out carefully by exploring and 
mapping of the mesenteric vessels and portal vein.
Identification of the common bile duct prior to dissection
at the head of the pancreas is mandatory and different
techniques have been used in order to identify the com-
mon bile duct, including identification of the common
bile duct by dissection in the hepatoduodenal ligament
and following the duct down behind the duodenum,
insertion of tube through the gallbladder down through
the cystic duct and common bile duct, cholangiogram
and infusion of saline through the gallbladder with
clamping of the first and third parts of the duodenum
after clamping of the pancreatic head and prior to resec-
tion to confirm duct patency (distension of the duode-
num indicates patency of the duct). Transection of the
pancreatic head was done using endo GIA (US Surgical,
Norwalk, CT, USA). Few cases and redo cases have been
done by transection with knife and closure of the pancre-
atic resection margin with 3/0 silk suture using figure of
8, penrose drain was usually left behind. One case was
done by laparoscopic technique. Postoperatively, patients
were fed within 48–72 hours. Blood glucose was moni-
tored frequently postoperatively. If the patient remained
hypoglycaemic (blood glucose ≤ 2 mmol/L), a second cycle
of medical therapy (diazoxide, octreotide) was started.
Glucose infusion was continued and adjusted according
to the babies’ blood sugar.
Results
All babies were the result of full-term pregnancies except
for five preterm babies. The birth weights ranged from 2.5
to 4.5 kg (median, 3.5 kg). The consanguinity was very
high in our group of patients. Seventeen parents were
first-degree cousins, eight were second-degree cousins
and five were far relatives. One family had seven affected
children and three families had two siblings with PHHI.
The current patient age ranged from 3 months to 19 years
(median, 5 years). The age of the first documented hypo-
glycaemia ranged from a few hours to 1 year (median, 
1 day), and the age at which the diagnosis was made
ranged from 10 days to 3 years (median, 2 months). Age
at surgery ranged from 1 month to 4 years (median, 2
months). Convulsion was the most common presenting
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symptom and was seen in 28 children. Sweating, tremor
and apnoea were seen in 20 patients. All patients were
severely hypoglycaemic on fasting with a median fasting
tolerance time of 90 minutes to induce hypoglycaemia.
All patients had inappropriately elevated insulin level and
required high glucose infusion of more than 12 mg/kg/
minute (range, 14–20 mg/kg/minute). Insulin levels dur-
ing hypoglycaemia ranged from 18 to 106 mU/mL. Insulin
to glucose ratio ranged from 0.5 to 3.8 (mean, 2.3). All
patients had negative urine ketones and normal growth
hormone, cortisol and ACTH levels, which were collected
during hypoglycaemia. Twenty-three patients had a normal
acylcarnitine profile by tandem MS. Thirty-two patients
had glucagon injection 30 μg/kg as a therapeutic measure
for hypoglycaemia and to confirm the diagnosis of hyper-
insulinism. Ammonia level was measured in 14 patients
and found to be elevated in one. MRI and CT studies
showed that 14 patients had brain atrophy and neurologi-
cal assessment showed that 18 babies had developmental
delay. Twelve patients had a cardiac murmur, ventricular
septal defect was detected in six and bicuspid valve in two.
Nine patients had successful medical management,
while the remaining 34 underwent near total pancreatec-
tomy because of failure of medical treatment. No patient
was found to have a localized lesion (adenoma). All of
them had open laparotomy except one who had a lapa-
roscopic pancreatectomy. Postoperative complications
included prolonged ileus in five patients and leakage 
in one, which stopped eventually. One patient had bile
leak from an opening in the gallbladder. There were no
injuries to the common bile duct. Two patients had recur-
rent intestinal obstruction requiring laparotomy. Four
patients had a repeat pancreatectomy, three of which were
performed shortly after the first (2–4 weeks) because of
failure to control hypoglycaemia. The fourth case had a
second operation 8 months after the first and was found
to have overgrowth of the remaining pancreas. The child
responded well to surgery. Side effects during medication
included hypertrichosis in 20 patients, leucopenia in four,
and thrombocytopenia in three. The duration of diaz-
oxide treatment ranged from 1 week to 4 years (median,
15 months). Octreotide were first used in 1992 and 27
patients were treated with octreotide as an adjunctive
therapy to diazoxide. The duration of octreotide treatment
ranged from 1 week to 5 years (median, 18 months). One
patient had the serious octreotide-related complication
of bowel gangrene, which resulted in short gut syndrome
with bowel length of 49 cm. He also had severe cardiomy-
opathy. Four patients died, two because of sepsis and two
because of hypoglycaemic seizure. Six patients were lost to
follow-up. Five patients were followed until the age of 
1 year. Four of them were diabetic and two had malabsorp-
tion symptoms. One patient had prolonged diazoxide
treatment for 10 years. Eighteen patients have significant
developmental delay. Eight patients had intelligent test
which ranged from 43 to 84 and four patients are blind and
deaf. All except three patients have normal height velocity.
Discussion
Insulin is normally released by the -cell of the pancreas,
which is controlled by KATP channels and the entry of cal-
cium, which is the specific stimulation of the exocytosis of
insulin. There are two proteins known to be necessary for
the balance of KATP channel and these two proteins are
coded for by the sulfonylurea receptor (SUR1) gene and
inward rectifying potassium channel subunit (Kir6.2)
gene.4,5,10 It has been reported that anomaly of this gene is
recognised in less than 60% of patients with PHHI, which
explained inappropriate release of insulin by the -cells. It
has been reported that the incidence of PHHI is 1/50,000
live births;2 however, in areas with high consanguinity such
as Saudi Arabia and Ashkenazi Jewish populations, the inci-
dence could be as high as 1/2,500 live births.3,11,12 Most of
the cases are sporadic but in our series, we have more than
67% with a family history as we have shown one family had
seven affected siblings and four families have more than
one child affected. Twenty of our patients had hypogly-
caemic convulsion and developmental delay. High percent-
age of patients with varying degrees of brain atrophy might
be the result of late referral and unresponsiveness to med-
ical therapy. Although there is no documented correlation
between the time of surgery and developmental delay, it is
clear that the later the referral, the more is the brain dam-
age. Hypoglycaemic convulsion was the commonest pre-
senting symptom. The majority of our children had high
insulin levels (36 mmol) and insulin to glucose ratios,
which may indicate that they harbour the SUR1/Kir6.2
mutations. Patients with SUR1/Kir6.2 mutations are usu-
ally unresponsive to medical therapy and require surgery.
These levels are higher than those reported in other 
studies.13,14
Pancreatomy in all patients in our series was per-
formed by the open technique, except in one patient who
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underwent laparoscopic subtotal pancreatectomy (85%).
During surgery, none of our patients were identified to
have a focal lesion. Four of our patients underwent a
repeat pancreatectomy because of failure to control hypo-
glycaemia, which accounts for about 9% of cases. Despite
this, we had four mortalities, none of which were related
to surgical intervention. We observed a lower rate of other
complications, particularly common bile duct injury,
which is probably related to careful identification of the
common bile duct. It has been reported that there is a
higher incidence of repeat pancreatectomy in patients
who undergo 90% resection,13 where in one series 18% of
patients who underwent less than 90% resection required
a further pancreatic resection.15 In another series of 
165 children of 95% and 98% pancreatectomy, only 4.8%
required further pancreatic resection.16 The extent of pan-
creatic resection in our patients ranged between 90% and
95% except in the laparoscopic case, which was about 85%.
Further resection was required in four cases accounting
for about 9% of pancreatectomy and we think our high
rate of resection compared to other series is because all our
cases were of a diffuse form. Pancreatic growth has been
implicated as a possible cause of recurrence of hypogly-
caemia and it was definitely observed in one of our babies,
which was done during the neonatal period. He had sig-
nificant residual and growth of the pancreas when re-
pancreatectomy was done 8 months later. This patient 
had responded very well to re-resection. Insulin dependent
diabetes appears to be related to pancreatic resection13,17,18
and we have found that four out of five cases in our group
above the age of 12 years have diabetes, and one of the
medically treated groups. Pancreatic exocrine function 
of one patient (14 years) has also been affected by pancre-
atic resection, two of our patients had significant malab-
sorption that required pancreatic enzyme supplement,
accounting for about 5%, and is comparable to literature
reports,19,20 with some up to 10%.
Medical therapy with diazoxide and octreotide has
been reported to be successful in some cases; however, 34
of our patients required pancreatectomy.
We conclude that PHHI is relatively common in Saudi
Arabia, which is related to high consanguinity. Early med-
ical intervention is extremely important to avoid neuro-
logical complications. We recommend prenatal counselling
in families with affected children. Surgery is required in
the majority of babies, but medical management can be
successful in certain cases. We believe that the natural 
history of this disease is the development of diabetes 
mellitus, which can be accelerated by pancreatectomy.
Care and spending more time to visualize the common
bile duct help to avoid injury.
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